 The combination of single-cell and spatial gene expression analysis technologies provides a more comprehensive understanding of tissue heterogeneity in clinical samples, allowing for the identification of biomarkers involved in cancer progression and rare boundary cells that contribute to tumor spread. This article was authored by Amanda Jansik, Robert Shalanski, Andrew D. Gostow, and others.